search
Back to results

A New Membrane Obturator Prothesis Concept for Soft Palate Defects (VELOMEMBRANE)

Primary Purpose

Mouth Neoplasms, Velopharyngeal Insufficiency, Speech Disorders

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Suersen and membraneous obturators evaluation
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mouth Neoplasms focused on measuring Randomized controlled trial, Palatal obturators

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult over 18 year-old
  • Acquired loss of velar or palato-velar substance (maxillectomies of Class I and II a-d, Brown 2010) following the excision of a tumor
  • Indication of Suersen obturator prosthesis rehabilitation
  • Possible dental rehabilitation with removable prosthesis (retention and stability prosthetic provided without the use of glue, mouth opening allowing fingerprints, presence of saliva, dexterity allowing the insertion and removal of prostheses, as well as the cleaning of devices)
  • Having given their consent to participate in the study
  • Speaking French, knowing how to read it
  • Available and motivated for regular follow-up during the study period

Exclusion Criteria:

  • Child under 18
  • Allergy to acrylic resin
  • Radiotherapy or chemotherapy in progress
  • Surgery of the veil programmed during the 3 months necessary for the realization and the wearing of the prostheses.
  • Loss of congenital or traumatic palato-velar substance
  • Maxillectomies including orbital floor or total maxillectomy
  • Pregnant or lactating woman
  • Participation in another interventional study
  • Inability to give informed consent

Sites / Locations

  • CHU de Bordeaux

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Suersen obturator then membraneous obturator

Membraneous obturator then Suersen obturator

Arm Description

Outcomes

Primary Outcome Measures

Voice Handicap Index (VHI) overall score
Min : 0 = Non handicap to Max : 120 = voice handicap maximum
Voice Handicap Index (VHI) overall score
Min : 0 = Non handicap to Max : 120 = voice handicap maximum

Secondary Outcome Measures

Deglutition Handicap Index (DHI) overall score
Min : 0 = Non handicap to Max : 120 = deglutition handicap maximum
Deglutition Handicap Index (DHI) overall score
Min : 0 = Non handicap to Max : 120 = deglutition handicap maximum
Deglutition Handicap Index (DHI) overall score
Min : 0 = Non handicap to Max : 120 = deglutition handicap maximum
Health-related quality of life EORTC QLQ-C30 questionnaire score
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Health-related quality of life EORTC QLQ-C30 questionnaire score
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Health-related quality of life EORTC QLQ-C30 questionnaire score
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Head and Neck quality of life EORTC QLQ-H&N35 questionnaire score
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Head and Neck quality of life EORTC QLQ-H&N35 questionnaire score
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Head and Neck quality of life EORTC QLQ-H&N35 questionnaire score
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life

Full Information

First Posted
June 24, 2019
Last Updated
February 23, 2023
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT04009811
Brief Title
A New Membrane Obturator Prothesis Concept for Soft Palate Defects
Acronym
VELOMEMBRANE
Official Title
A New Membrane Obturator Prothesis Concept for Soft Palate Defects
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
July 17, 2020 (Actual)
Primary Completion Date
April 10, 2022 (Actual)
Study Completion Date
July 15, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
When soft palate defects lead to palatal insufficiency, the patient's quality of life is affected by difficulties swallowing, hypernasality, and poor intelligibility of speech. If immediate surgical reconstruction is not an option, the patient may benefit from the placement of a rigid obturator prosthesis. Unfortunately, the residual muscle stumps are often unable to adequately move this stiff and inert obturator to properly restore the velopharyngeal valve function. The objective of this case report was to describe the use of a membrane obturator prosthesis that incorporates a dental dam to compensate for the soft palate defect.
Detailed Description
The velopharyngeal sphincter seals the oropharynx from the nasopharynx during swallowing and speech. This three-dimensional muscular valve closes through the synergistic behavior of the soft palate and the lateral and posterior walls of the pharynx. A soft palate defect surgically acquired in the context of oral cancer may impede complete closure and lead to a palatopharyngeal insufficiency. The resultant airflow escape results in hypernasality, poor speech intelligibility, and swallowing problems (such as leakage of foods and fluids into the nasal airways). The best way to rehabilitate and restore chewing and swallowing is one of the top ten research priorities in head and neck cancer. When the velopharyngeal function cannot be immediately restored with surgical reconstruction, patients can benefit from an obturator prosthesis. This obturator is a rigid extension of acrylic resin positioned at the level of the hard palate that provides surface contact for the remaining musculature. Often, the residual muscle stumps cannot move adequately around this stiff and inert obturator to properly restore the velopharyngeal valve function. The resulting blockage, or free space between the tissues and obturator, is a main cause of prosthetic failure. Subsequently, in many cases, oral functions remain impaired, with a negative impact on the patient's quality of life. The compensating treatment consists of a provisional removable partial denture (RPD) with a membrane obturator. The membrane consisted of a thick dental dam shaped with scissors to create a 10-mm overlap with the pharyngeal walls that was then perforated with four holes using punch pliers. The follow-up ends after the last visit. However, our team can provide cares of any patient seeking for dental care, prosthetic treatments and routine follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mouth Neoplasms, Velopharyngeal Insufficiency, Speech Disorders, Deglutition Disorders
Keywords
Randomized controlled trial, Palatal obturators

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Suersen obturator then membraneous obturator
Arm Type
Experimental
Arm Title
Membraneous obturator then Suersen obturator
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Suersen and membraneous obturators evaluation
Intervention Description
The patient will wear one month each obturator prothesis (Suersen and membraneous obturators). The order of evaluation will be randomized in two arms. Half of patient will first wear one month the membranous obturator then one month the Suersen, the other half of patient will first wear one month the Suersen obturator and one month the membranous obturator.
Primary Outcome Measure Information:
Title
Voice Handicap Index (VHI) overall score
Description
Min : 0 = Non handicap to Max : 120 = voice handicap maximum
Time Frame
Visit M2 : one month after first obturator supply i.e. two months after inclusion
Title
Voice Handicap Index (VHI) overall score
Description
Min : 0 = Non handicap to Max : 120 = voice handicap maximum
Time Frame
Visit M3 : one month after second obturator supply i.e. three months after inclusion
Secondary Outcome Measure Information:
Title
Deglutition Handicap Index (DHI) overall score
Description
Min : 0 = Non handicap to Max : 120 = deglutition handicap maximum
Time Frame
Visit M1 : one month after inclusion
Title
Deglutition Handicap Index (DHI) overall score
Description
Min : 0 = Non handicap to Max : 120 = deglutition handicap maximum
Time Frame
Visit M2 : two months after inclusion
Title
Deglutition Handicap Index (DHI) overall score
Description
Min : 0 = Non handicap to Max : 120 = deglutition handicap maximum
Time Frame
Visit M3 : three months after inclusion
Title
Health-related quality of life EORTC QLQ-C30 questionnaire score
Description
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Time Frame
Visit M1 : one month after inclusion
Title
Health-related quality of life EORTC QLQ-C30 questionnaire score
Description
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Time Frame
Visit M2 : two months after inclusion
Title
Health-related quality of life EORTC QLQ-C30 questionnaire score
Description
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Time Frame
Visit M3 : three months after inclusion
Title
Head and Neck quality of life EORTC QLQ-H&N35 questionnaire score
Description
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Time Frame
Visit M1 : one month after inclusion
Title
Head and Neck quality of life EORTC QLQ-H&N35 questionnaire score
Description
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Time Frame
Visit M2 : two months after inclusion
Title
Head and Neck quality of life EORTC QLQ-H&N35 questionnaire score
Description
Min : 0 = lower level of quality of life to Max : 100 = better level of quality of life
Time Frame
Visit M3 : three months after inclusion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult over 18 year-old Acquired loss of velar or palato-velar substance (maxillectomies of Class I and II a-d, Brown 2010) following the excision of a tumor Indication of Suersen obturator prosthesis rehabilitation Possible dental rehabilitation with removable prosthesis (retention and stability prosthetic provided without the use of glue, mouth opening allowing fingerprints, presence of saliva, dexterity allowing the insertion and removal of prostheses, as well as the cleaning of devices) Having given their consent to participate in the study Speaking French, knowing how to read it Available and motivated for regular follow-up during the study period Exclusion Criteria: Child under 18 Allergy to acrylic resin Radiotherapy or chemotherapy in progress Surgery of the veil programmed during the 3 months necessary for the realization and the wearing of the prostheses. Loss of congenital or traumatic palato-velar substance Maxillectomies including orbital floor or total maxillectomy Pregnant or lactating woman Participation in another interventional study Inability to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elise ARRIVE, DDS
Organizational Affiliation
Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique (USMR) du CHU de Bordeaux
Official's Role
Study Chair
Facility Information:
Facility Name
CHU de Bordeaux
City
Bordeaux
ZIP/Postal Code
33076
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35303932
Citation
Naveau A, Kret M, Plaire V, Delorme O, Marchi S, de Bataille C, Destruhaut F, Arrive E, Bou C. Efficacy of a new membrane obturator prosthesis in terms of speech, swallowing, and the quality of life of patients with acquired soft palate defects: study protocol of the VELOMEMBRANE randomized crossover trial. Trials. 2022 Mar 18;23(1):221. doi: 10.1186/s13063-022-06163-6.
Results Reference
derived

Learn more about this trial

A New Membrane Obturator Prothesis Concept for Soft Palate Defects

We'll reach out to this number within 24 hrs